CMPXCompass Therapeutics, Inc.

0.79+3.85%· post 0.79

Mkt cap$141.6MRevenue$850,000Q2 FY24Revenue—

UPBUpstream Bio, Inc.

3.41+4.28%· post 3.40

ClosedOct 30 '26

Mkt cap$186.1MRevenue$773,000Q2 FY26Revenue$3MFY25

Compare

ClosedOct 30 '26

CMPXCompass Therapeutics, Inc.

UPBUpstream Bio, Inc.

0.79+3.85%post 0.79

Price

3.41+4.28%post 3.40

$141.6M

Mkt cap

$186.1M

Q2 FY24$850,000

Revenue

$773,000Q2 FY26

—

Revenue

$3MFY25

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

UPBUpstream Bio, Inc.

Mkt capRevenueRevenue

Compare

CMPXCompass Therapeutics, Inc.

UPBUpstream Bio, Inc.

Price

Mkt cap

Revenue

Save comparison

Supply-chain overlap

direct ties · both sidesSources

direct ties · both sides

Only CMPX 5

—ABL Biounlistedsupplier

—Adimabunlistedsupplier

—B. Riley Securitiesunlistedsupplier

—Elpiscience Biopharmaceuticalsunlistedsupplier

1 more · CMPX chain

Shared 0

No shared counterparties.

Only UPB 5

REGNRegeneron Pharmaceuticalssupplier

—Astellas Pharmaunlistedsupplier

—Lonza Salesunlistedsupplier

—Wuxi Biologics (Hong Kong)unlistedsupplier

1 more · UPB chain

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CMPX compared with UPB: revenue, margins and what each company keeps, and the suppliers and customers both name

Supply-chain overlap

Supply-chain overlap

Supply-chain overlap